Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
5 Mar 2021	Submitted	Original manuscript
9 Mar 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
10 Mar 2021	Editorially accepted
17 May 2021	Article published	10.1186/s13063-021-05181-0

Back to article page